Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology
- PMID: 37183534
- DOI: 10.1002/ijgo.14850
Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology
Abstract
Objective: To examine the association between assisted reproductive technology (ART) and abnormal placentation.
Methods: This is a retrospective cohort study querying the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample. The study population included 14, 970, 064 deliveries for national estimates from January 2012 to September 2015. The exposure was 48, 240 pregnancies after ART. The main outcome measure encompassed three abnormal placentation pathologies (placenta previa [PP], placenta accreta spectrum [PAS], and vasa previa [VP]). Propensity score matching was performed to assess the exposure-outcome association.
Results: Pregnancy after ART was more likely to have a diagnosis of PAS (2.8 vs 1.0 per 1000 deliveries; adjusted odds ratio [aOR], 2.06 [95% confidence interval (CI), 1.44-2.93]), PP (24.5 vs 8.6 per 1000; aOR, 2.98 [95% CI, 2.64-3.35]), and VP (2.3 vs <0.3 per 1000; aOR, 11.3 [95% CI, 5.86-21.8]) compared with pregnancy without ART. Similarly, pregnancy after ART was associated with an increased likelihood of having multiple types of abnormal placentation, including VP with PP (aOR, 15.4 [95% CI, 6.15-38.4]) and PAS with PP (aOR, 2.80 [95% CI, 1.32-5.92]) compared with non-ART pregnancy.
Conclusions: This national-level analysis suggests that pregnancy after ART is associated with a significantly increased risk of abnormal placentation, including PAS, PP, and VP.
Keywords: assisted reproductive technology; placenta accreta spectrum; placenta previa; pregnancy; vasa previa.
© 2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
References
REFERENCES
-
- Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786-1801.
-
- Fauser BC. Towards the global coverage of a unified registry of IVF outcomes. Reprod Biomed Online. 2019;38(2):133-137.
-
- SART. National Summary Report 2020. Available from: https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=...
-
- Ghidini A, Gandhi M, McCoy J, Kuller JA. Society for Maternal-Fetal Medicine Consult Series #60: management of pregnancies resulting from in vitro fertilization. Am J Obstet Gynecol. 2022;226(3):B2-b12.
-
- Sunderam S, Kissin DM, Zhang Y, et al. Assisted reproductive technology surveillance - United States, 2018. MMWR Surveill Summ. 2022;71(4):1-19.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
